SUNRISE, Fla., June 6 /PRNewswire-FirstCall/ -- Bioheart, Inc. (Nasdaq: BHRT) will host its 2008 Annual Meeting of Shareholders on Wednesday, July 30, 2008 at Chispa Restaurant, located at 11500 NW 41st Street in Doral, Florida. The meeting will commence at 9:00 am EASTERN.
Interested parties may listen to the Bioheart, Inc. 2008 Annual Meeting via telephone by calling (877) 858-9308 (domestic) or (706) 643-0580 (international). To listen to the Annual Meeting and to view the accompanying slide presentation via the Internet, log onto http://www.bioheartinc.com and click on the 2008 Annual Meeting of Shareholders link. Please note that the broadcast will be listen-only.
An audio only replay of the Annual Meeting will be available at (800) 642- 1687 (domestic) or (706) 645-9291 (international), access number 50330882 for 3 days following the call, and the web cast with slide presentation will be archived on the Company's website, http://www.bioheartinc.com, for 30 days.
About Bioheart, Inc.:
Bioheart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.
Its lead product candidate, MyoCell(R), is an innovative clinical cell
therapy designed to populate regions of scar tissue within a patient's
heart with new living cells for the purpose of improving cardiac function
in chronic heart failure patients. The Company's pipeline includes multiple
product candidates for the treatment of heart damage, including Bioheart
Acute Cell Therapy, an autologous, adipose-tissue derived stem cell
treatment for acute heart damage, and MyoCell(R) SDF-1, a therapy utilizing
autologous cells that are genetically modified to express additional
potentially therapeutic proteins.
|SOURCE Bioheart, Inc.|
Copyright©2008 PR Newswire.
All rights reserved